Medium 6.3Published Sep 3, 2026

CVE-2026-85241SpecterOps BloodHound Graph Write Endpoint v2.go NewV2API improper authorization

Updated under an hour ago (2026-10-19 09:40 UTC)

Does this affect you?

It affects SpecterOps BloodHound. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

Do this next

Start free and add your stack

Free account, 1 product

Every CVE for SpecterOps BloodHound

Exploited in the last 30 days

A weakness has been identified in SpecterOps BloodHound up to 9.5.1. The affected element is the function NewV2API of the file cmd/api/src/api/registration/v2.go of the component Graph Write Endpoint. Executing a manipulation can lead to improper authorization. It is possible to launch the attack remotely. Upgrading to version 9.6.0-rc1, 9.6.0 and 9.7.0-rc3 is sufficient to fix this issue. This patch is called 39d1276a63e95a7713f954dea632a19651d9cebb. You should upgrade the affected component.

CVSS: 6.3 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L/E:X/RL:O/RC:C
Weakness (CWE): CWE-285, CWE-266
Known exploited: Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days): Not loaded for this CVE
Assigned by: VulDB
NVD analysis: Deferred
Record last updated: Sep 4, 2026
First seen by InfoSec Signals: Oct 9, 2026

Affected products

Affected products

SpecterOps BloodHound specterops:bloodhound	9.0.0; 9.1.0; 9.2.2; 9.4.0; 9.5.0; 9.5.1; 9.6.0-rc1 not affected; 9.6.0 not affected; and 1 more ranges	CNA record

References

https://vuldb.com/vuln/398471vdb-entry, technical-description
https://vuldb.com/vuln/398471/ctisignature, permissions-required
https://vuldb.com/cve/CVE-2026-85241third-party-advisory
https://vuldb.com/submit/894488third-party-advisory
https://github.com/SpecterOps/BloodHound/commit/39d1276a63e95a7713f954dea632a19651d9cebbpatch
https://github.com/SpecterOps/BloodHound/releases/tag/v9.6.0-rc1patch
https://github.com/SpecterOps/BloodHound/product

The CVE record on cve.org NVD's entry

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.